NEW YORK ─ Novacyt on Wednesday announced that it has obtained CE marking for a next-generation high-throughput PCR test for COVID-19, called COVID-HT Direct, and is making the test available in Europe and other regions that accept the designation.
COVID-HT Direct eliminates the need for automated extraction systems in a high-volume PCR laboratory, reducing processing time, cost, and labor by up to 30 percent, the firm said.